69 related articles for article (PubMed ID: 17449101)
1. The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.
Ossevoort M; Zaldumbide A; te Velthuis AJ; Melchers M; Ressing ME; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Jul; 44(14):3588-96. PubMed ID: 17449101
[TBL] [Abstract][Full Text] [Related]
2. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus.
Zaldumbide A; Ossevoort M; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Feb; 44(6):1352-60. PubMed ID: 16828498
[TBL] [Abstract][Full Text] [Related]
3. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
Tellam JT; Lekieffre L; Zhong J; Lynn DJ; Khanna R
PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
[TBL] [Abstract][Full Text] [Related]
4. Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.
Ossevoort M; Visser BM; van den Wollenberg DJ; van der Voort EI; Offringa R; Melief CJ; Toes RE; Hoeben RC
Gene Ther; 2003 Nov; 10(24):2020-8. PubMed ID: 14566361
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
[TBL] [Abstract][Full Text] [Related]
7. Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.
Mukherjee S; Trivedi P; Dorfman DM; Klein G; Townsend A
J Exp Med; 1998 Feb; 187(3):445-50. PubMed ID: 9449725
[TBL] [Abstract][Full Text] [Related]
8. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
Yin Y; Manoury B; Fåhraeus R
Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
[TBL] [Abstract][Full Text] [Related]
9. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
[TBL] [Abstract][Full Text] [Related]
12. Gamma-herpesvirus latency requires T cell evasion during episome maintenance.
Bennett NJ; May JS; Stevenson PG
PLoS Biol; 2005 Apr; 3(4):e120. PubMed ID: 15769185
[TBL] [Abstract][Full Text] [Related]
13. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.
Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T
Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128
[TBL] [Abstract][Full Text] [Related]
15. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
Wang Y; Finan JE; Middeldorp JM; Hayward SD
Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transcription by the Epstein-Barr virus nuclear antigen EBNA 2.
Palermo RD; Webb HM; Gunnell A; West MJ
Biochem Soc Trans; 2008 Aug; 36(Pt 4):625-8. PubMed ID: 18631129
[TBL] [Abstract][Full Text] [Related]
17. Defective Marek's disease virus DNA contains a gene encoding a potential nuclear DNA binding protein and a HSV a-like sequence.
Camp HS; Silva RF; Coussens PM
Virology; 1993 Oct; 196(2):484-95. PubMed ID: 8396799
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
Oncogene; 2000 Mar; 19(14):1801-6. PubMed ID: 10777214
[TBL] [Abstract][Full Text] [Related]
19. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
Gao J; Coulson JM; Whitehouse A; Blake N
J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
[TBL] [Abstract][Full Text] [Related]
20. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]